netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 29 of 29


Details
LDL Link Added : MHRA Drug Safety Update (May 2020): Immunomodulatory drugs and pregnancy prevention: temporary advice for management during coronavirus (COVID-19) : https://www.gov.uk/drug-safety-update/immunomodulatory-drugs-and-pregnancy-prevention-tempora
06/07/2023 14:21:58
(rpaylor )
LDL Link Added : Letter sent to healthcare professionals (Nov 2016): lenalidomide (Revlimid▼): new advice about viral reactivation : https://www.gov.uk/drug-safety-update/letters-sent-to-healthcare-professionals-in-november-2016
06/07/2023 14:21:24
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (Jan 2013): Lenalidomide (Revlimid): risk of serious hepatic adverse drug reactions : https://www.gov.uk/drug-safety-update/lenalidomide-revlimid-risk-of-serious-hepatic-adverse-drug-reactions
06/07/2023 14:21:02
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (Nov 2011): Lenalidomide (Revlimid▼): update on risk of second primary malignancy : https://www.gov.uk/drug-safety-update/lenalidomide-revlimid-update-on-risk-of-second-primary-malignancy
06/07/2023 14:20:43
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (Feb 2011): Lenalidomide: risk of thrombosis and thromboembolism : https://www.gov.uk/drug-safety-update/lenalidomide-risk-of-thrombosis-and-thromboembolism
06/07/2023 14:20:18
(rpaylor )
LDL Link Added : NICE TA171: Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies : https://www.nice.org.uk/guidance/ta171
06/07/2023 12:12:14
(rpaylor )
LUP Section link 19436 Updated: 08.02.04 : NICE TA586: Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib : https://www.nice.org.uk/guidance/ta586...
17/11/2022 14:09:43
(DavidS )
LDL Link Added : NICE TA27: Lenalidomide with rituximab for previously treated follicular lymphoma : https://www.nice.org.uk/guidance/ta627
17/11/2022 14:09:31
(DavidS )
UPD sitematrix Changed from 0 to
17/11/2022 14:09:02
(DavidS )
UPD FurtherInformation Changed from

  • Approved for multiple myeloma in line with NICE - approved for myelodysplastic syndrome with 5q deletion in line with NICE. 
17/11/2022 14:09:02
(DavidS )
UPD Lenalidomide NICE TA627
17/11/2022 14:09:02
(DavidS )
UPD Published from Draft Mode
20/05/2021 13:31:07
(LoweryM )
UPD Lenalidomide updated
20/05/2021 13:30:50
(LoweryM )
LDL Link Added : NICE TA680: Lenalidomide maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma : https://www.nice.org.uk/guidance/ta680
19/05/2021 16:34:48
(DavidS )
UPD Lenalidomide NICE TA680
19/05/2021 16:34:18
(DavidS )
UPD Published from Draft Mode
21/02/2020 09:37:54
(LoweryM )
UPD Lenalidomide added SSC2086
21/02/2020 09:37:37
(LoweryM )
UPD Lenalidomide updated
13/02/2020 14:23:48
(DavidS )
LDL Link Added : NICE TA: Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib : https://www.nice.org.uk/guidance/ta586
13/02/2020 14:23:10
(DavidS )
UPD Lenalidomide updated. NHS England commissioning policy
13/02/2020 14:22:19
(DavidS )
LDL Link Added : NICE TA587: Lenalidomide plus dexamethasone for previously untreated multiple myeloma : https://www.nice.org.uk/guidance/ta587
13/02/2020 14:21:01
(DavidS )
LDL Link Added : NICE TA322: Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality : https://www.nice.org.uk/guidance/ta322
01/02/2017 16:13:00
(DavidS )
UPD Lenalidomide b
01/02/2017 16:12:16
(DavidS )
UPD Lenalidomide b
24/01/2017 16:47:55
(WhitehallJ )
UPD Lenalidomide b
24/01/2017 16:45:02
(WhitehallJ )
UPD Published from Draft Mode
24/01/2017 16:36:15
(WhitehallJ )
UPD Lenalidomide b
24/01/2017 16:36:03
(WhitehallJ )
UPD Lenalidomide build
29/11/2016 09:00:39
(DavidS )
UPD Lenalidomide build
29/11/2016 08:59:44
(DavidS )

 

 
netFormulary